{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:08:09Z","timestamp":1784815689844,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-025-01913-y","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T05:03:09Z","timestamp":1753765389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular Interactions Between NK Cells and Acute Leukemic Cells: KIR2DL5 Drastically Limits NK Cell Responses"],"prefix":"10.1007","volume":"45","author":[{"given":"Enora","family":"Ferron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Jullien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Braud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Fourgeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Bastien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perla","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Willem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolwenn","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Walencik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Peterlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Lebourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Gagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Poschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Reti\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"1913_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.coi.2015.11.001","volume":"38","author":"A Iannello","year":"2016","unstructured":"Iannello A, Thompson TW, Ardolino M, Marcus A, Raulet DH. Immunosurveillance and immunotherapy of tumors by innate immune cells. Curr Opin Immunol. 2016;38:52\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"1913_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ijc.2910160204","volume":"16","author":"RB Herberman","year":"1975","unstructured":"Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer. 1975;16(2):216\u201329.","journal-title":"Int J Cancer"},{"key":"1913_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","volume":"25","author":"N Anfossi","year":"2006","unstructured":"Anfossi N, Andr\u00e9 P, Guia S, Falk CS, Roetynck S, Stewart CA, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity. 2006;25:331\u201342.","journal-title":"Immunity"},{"key":"1913_CR4","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.4049\/jimmunol.1502469","volume":"196","author":"JE Boudreau","year":"2016","unstructured":"Boudreau JE, Mulrooney TJ, Le Luduec J-B, Barker E, Hsu KC. KIR3DL1 and HLA-B density and binding calibrate NK education and response to HIV. J Immunol. 2016;196:3398\u2013410.","journal-title":"J Immunol"},{"key":"1913_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.it.2005.02.007","volume":"26","author":"C Bottino","year":"2005","unstructured":"Bottino C, Castriconi R, Moretta L, Moretta A. Cellular ligands of activating NK receptors. Trends Immunol. 2005;26:221\u20136.","journal-title":"Trends Immunol"},{"key":"1913_CR6","doi-asserted-by":"publisher","first-page":"208ra145","DOI":"10.1126\/scitranslmed.3006702","volume":"5","author":"A Horowitz","year":"2013","unstructured":"Horowitz A, Strauss-Albee DM, Leipold M, Kubo J, Nemat-Gorgani N, Dogan OC, et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med. 2013;5:208ra145.","journal-title":"Sci Transl Med."},{"key":"1913_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.molimm.2004.07.029","volume":"42","author":"M Uhrberg","year":"2005","unstructured":"Uhrberg M. Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation. Mol Immunol. 2005;42:471\u20135.","journal-title":"Mol Immunol"},{"key":"1913_CR8","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1182\/blood-2008-03-143727","volume":"112","author":"M Yawata","year":"2008","unstructured":"Yawata M, Yawata N, Draghi M, Partheniou F, Little A-M, Parham P. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood. 2008;112:2369\u201380.","journal-title":"Blood"},{"key":"1913_CR9","doi-asserted-by":"publisher","first-page":"1389358","DOI":"10.3389\/fimmu.2024.1389358","volume":"15","author":"E Ferron","year":"2024","unstructured":"Ferron E, David G, Willem C, Legrand N, Salameh P, Anquetil L, et al. Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence. Front Immunol. 2024;15:1389358.","journal-title":"Front Immunol"},{"key":"1913_CR10","doi-asserted-by":"crossref","unstructured":"Makanga DR, Da Rin de Lorenzo F, David G, Willem C, Dubreuil L, Legrand N, et al. Genetic and molecular basis of heterogeneous NK cell responses against acute leukemia. Cancers (Basel). 2020;12:E1927.","DOI":"10.3390\/cancers12071927"},{"key":"1913_CR11","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","volume":"116","author":"NK Bj\u00f6rkstr\u00f6m","year":"2010","unstructured":"Bj\u00f6rkstr\u00f6m NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA, et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood. 2010;116:3853\u201364.","journal-title":"Blood"},{"key":"1913_CR12","doi-asserted-by":"publisher","first-page":"e11966","DOI":"10.1371\/journal.pone.0011966","volume":"5","author":"V B\u00e9ziat","year":"2010","unstructured":"B\u00e9ziat V, Descours B, Parizot C, Debr\u00e9 P, Vieillard V. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE. 2010;5:e11966.","journal-title":"PLoS ONE"},{"key":"1913_CR13","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1182\/blood-2010-04-282301","volume":"116","author":"S Lopez-Verg\u00e8s","year":"2010","unstructured":"Lopez-Verg\u00e8s S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood. 2010;116:3865\u201374.","journal-title":"Blood"},{"key":"1913_CR14","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.4049\/jimmunol.1301138","volume":"191","author":"Z Djaoud","year":"2013","unstructured":"Djaoud Z, David G, Bressollette C, Willem C, Rettman P, Gagne K, et al. Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: Functional impact in controlling CMV-infected dendritic cells. J Immunol. 2013;191:2708\u201316.","journal-title":"J Immunol"},{"key":"1913_CR15","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1182\/blood-2005-09-3682","volume":"107","author":"M Gum\u00e1","year":"2006","unstructured":"Gum\u00e1 M, Budt M, S\u00e1ez A, Brckalo T, Hengel H, Angulo A, et al. Expansion of CD94\/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood. 2006;107:3624\u201331.","journal-title":"Blood"},{"issue":"8","key":"1913_CR16","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","volume":"25","author":"L Rebuffet","year":"2024","unstructured":"Rebuffet L, Melsen JE, Escali\u00e8re B, Basurto-Lozada D, Bhandoola A, Bj\u00f6rkstr\u00f6m NK, et al. High-dimensional single-cell analysis of human natural killer cell heterogeneity. Nat Immunol. 2024;25(8):1474\u201388.","journal-title":"Nat Immunol"},{"key":"1913_CR17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.immuni.2018.09.009","volume":"49","author":"A Crinier","year":"2018","unstructured":"Crinier A, Milpied P, Escali\u00e8re B, Piperoglou C, Galluso J, Balsamo A, et al. High-dimensional single-cell analysis identifies organ-specific signatures and conserved NK cell subsets in humans and mice. Immunity. 2018;49:971-986.e5.","journal-title":"Immunity"},{"key":"1913_CR18","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1002\/eji.200838407","volume":"38","author":"M Morvan","year":"2008","unstructured":"Morvan M, David G, S\u00e9bille V, Perrin A, Gagne K, Willem C, et al. Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions. Eur J Immunol. 2008;38:3474\u201386.","journal-title":"Eur J Immunol"},{"key":"1913_CR19","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.4049\/jimmunol.1801489","volume":"202","author":"C Willem","year":"2019","unstructured":"Willem C, Makanga DR, Guillaume T, Maniangou B, Legrand N, Gagne K, et al. Impact of KIR\/HLA incompatibilities on NK cell reconstitution and clinical outcome after T cell-replete haploidentical hematopoietic stem cell transplantation with posttransplant cyclophosphamide. J Immunol. 2019;202:2141\u201352.","journal-title":"J Immunol"},{"key":"1913_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1399-0039.2004.00303.x","volume":"64","author":"JY Sun","year":"2004","unstructured":"Sun JY, Gaidulis L, Miller MM, Goto RM, Rodriguez R, Forman SJ, et al. Development of a multiplex PCR-SSP method for Killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens. 2004;64:462\u20138.","journal-title":"Tissue Antigens"},{"key":"1913_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/ajcp\/100.5.534","volume":"100","author":"MJ Borowitz","year":"1993","unstructured":"Borowitz MJ, Lynn Guenther K, Shults KE, Stelzer GT. Immunophenotyping of acute leukemia by flow cytometric analysis: Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol. 1993;100:534\u201340.","journal-title":"Am J Clin Pathol"},{"key":"1913_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1164\/rccm.202110-2324OC","volume":"206","author":"T Chaumette","year":"2022","unstructured":"Chaumette T, Cinotti R, Moll\u00e9 A, Solomon P, Castain L, Fourgeux C, et al. Monocyte signature associated with herpes simplex virus reactivation and neurological recovery after brain injury. Am J Respir Crit Care Med. 2022;206:295\u2013310.","journal-title":"Am J Respir Crit Care Med"},{"key":"1913_CR23","doi-asserted-by":"publisher","unstructured":"Charpentier E, Cornec M, Dumont S, Meistermann D, Bordron P, David L, et al. 3\u2019 RNA sequencing for robust and low-cost gene expression profiling. 2021. https:\/\/doi.org\/10.21203\/rs.3.pex-1336\/v1","DOI":"10.21203\/rs.3.pex-1336\/v1"},{"key":"1913_CR24","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.3390\/jcm11113229","volume":"11","author":"T Letellier","year":"2022","unstructured":"Letellier T, Kervella D, Sadek A, Masset C, Garandeau C, Fourgeux C, et al. Time-limited therapy with belatacept in kidney transplant recipients. J Clin Med. 2022;11:3229.","journal-title":"J Clin Med"},{"key":"1913_CR25","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.3390\/cancers12123595","volume":"12","author":"L Dubreuil","year":"2020","unstructured":"Dubreuil L, Maniangou B, Chevallier P, Qu\u00e9m\u00e9ner A, Legrand N, B\u00e9n\u00e9 MC, et al. Centromeric KIR AA individuals harbor particular KIR alleles conferring beneficial NK cell features with implications in haplo-identical hematopoietic stem cell transplantation. Cancers. 2020;12:3595.","journal-title":"Cancers"},{"key":"1913_CR26","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/eji.201243007","volume":"43","author":"K Gagne","year":"2013","unstructured":"Gagne K, Willem C, Legrand N, Djaoud Z, David G, Rettman P, et al. Both the nature of KIR3DL1 alleles and the KIR3DL1\/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population. Eur J Immunol. 2013;43:1085\u201398.","journal-title":"Eur J Immunol"},{"key":"1913_CR27","doi-asserted-by":"publisher","first-page":"e163620","DOI":"10.1172\/JCI163620","volume":"132","author":"X Ren","year":"2022","unstructured":"Ren X, Peng M, Xing P, Wei Y, Galbo PM, Corrigan D, et al. Blockade of the immunosuppressive KIR2DL5\/PVR pathway elicits potent human NK cell-mediated antitumor immunity. J Clin Invest. 2022;132:e163620.","journal-title":"J Clin Invest"},{"key":"1913_CR28","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097\u2013100.","journal-title":"Science"},{"key":"1913_CR29","doi-asserted-by":"publisher","first-page":"1111419","DOI":"10.3389\/fimmu.2023.1111419","volume":"14","author":"R Meazza","year":"2023","unstructured":"Meazza R, Ruggeri L, Guolo F, Minetto P, Canevali P, Loiacono F, et al. Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire. Front Immunol. 2023;14:1111419.","journal-title":"Front Immunol"},{"key":"1913_CR30","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1182\/blood-2002-07-2103","volume":"101","author":"JM Brenchley","year":"2003","unstructured":"Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711\u201320.","journal-title":"Blood"},{"key":"1913_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/cei\/uxae040","volume":"217","author":"LP Covre","year":"2024","unstructured":"Covre LP, Fantecelle CH, Queiroz AM, Fardin JM, Miranda PH, Henson S, et al. NKG2C+CD57+ natural killer cells with senescent features are induced during cutaneous leishmaniasis and accumulate in patients with lesional healing impairment. Clin Exp Immunol. 2024;217:279\u201390.","journal-title":"Clin Exp Immunol"},{"key":"1913_CR32","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI125916","volume":"129","author":"A Merino","year":"2019","unstructured":"Merino A, Zhang B, Dougherty P, Luo X, Wang J, Blazar BR, et al. Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming. J Clin Invest. 2019;129:3770\u201385.","journal-title":"J Clin Invest"},{"issue":"5","key":"1913_CR33","first-page":"e740","volume":"2024","author":"F Gao","year":"2020","unstructured":"Gao F, Mora MC, Constantinides M, Co\u00ebnon L, Multrier C, Vaillant L, et al. Feeder cell training shapes the phenotype and function of in vitro expanded natural killer cells. MedComm. 2020;2024(5):e740.","journal-title":"MedComm"},{"key":"1913_CR34","doi-asserted-by":"publisher","first-page":"1374068","DOI":"10.3389\/fimmu.2024.1374068","volume":"15","author":"A Witalisz-Siepracka","year":"2024","unstructured":"Witalisz-Siepracka A, Denk C-M, Zd\u00e1rsky B, Hofmann L, Edtmayer S, Harm T, et al. STAT3 in acute myeloid leukemia facilitates natural killer cell-mediated surveillance. Front Immunol. 2024;15:1374068.","journal-title":"Front Immunol"},{"key":"1913_CR35","doi-asserted-by":"publisher","first-page":"751834","DOI":"10.3389\/fonc.2021.751834","volume":"11","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Chen J, Wang J, Guan W, Wang M, Zhang L, et al. Acute myeloid leukemia epigenetic immune escape from nature killer cells by ICAM-1. Front Oncol. 2021;11:751834.","journal-title":"Front Oncol"},{"key":"1913_CR36","first-page":"265","volume":"6","author":"E Archimbaud","year":"1992","unstructured":"Archimbaud E, Thomas X, Campos L, Magaud JP, Dor\u00e9 JF, Fiere D. Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis. Leukemia. 1992;6:265\u201371.","journal-title":"Leukemia"},{"key":"1913_CR37","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1080\/10428194.2020.1742902","volume":"61","author":"R Thulasi Raman","year":"2020","unstructured":"Thulasi Raman R, Anurekha M, Lakshman V, Balasubramaniam R, Ramya U, Revathi R. Immunophenotypic modulation in pediatric B lymphoblastic leukemia and its implications in MRD detection. Leuk Lymphoma. 2020;61:1974\u201380.","journal-title":"Leuk Lymphoma"},{"key":"1913_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood-2005-04-1351","volume":"107","author":"YT Bryceson","year":"2006","unstructured":"Bryceson YT, March ME, Ljunggren H-G, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood. 2006;107:159\u201366.","journal-title":"Blood"},{"key":"1913_CR39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41586-019-1410-1","volume":"572","author":"AM Paczulla","year":"2019","unstructured":"Paczulla AM, Rothfelder K, Raffel S, Konantz M, Steinbacher J, Wang H, et al. Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion. Nature. 2019;572:254\u20139.","journal-title":"Nature"},{"key":"1913_CR40","doi-asserted-by":"publisher","unstructured":"Ren X, Peng M, Xing P, Wei Y, Galbo PM, Corrigan D, et al. Blockade of the immunosuppressive KIR2DL5\/PVR pathway elicits potent human NK cell\u2013mediated antitumor immunity. J Clin Invest. 2022;132. https:\/\/doi.org\/10.1172\/JCI163620","DOI":"10.1172\/JCI163620"},{"key":"1913_CR41","doi-asserted-by":"publisher","first-page":"e1010572","DOI":"10.1371\/journal.ppat.1010572","volume":"18","author":"P Fittje","year":"2022","unstructured":"Fittje P, H\u0153lzemer A, Garcia-Beltran WF, Vollmers S, Niehrs A, Hagemann K, et al. HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells. PLoS Pathog. 2022;18:e1010572.","journal-title":"PLoS Pathog"},{"key":"1913_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ni.1674","volume":"10","author":"X Yu","year":"2009","unstructured":"Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, Irving B, et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol. 2009;10:48\u201357.","journal-title":"Nat Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01913-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01913-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01913-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:45:31Z","timestamp":1777304731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01913-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1913"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01913-y","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"118"}}